Literature DB >> 34956771

An Extremely Rare Case of Metastatic Merkel Carcinoma of the Liver.

Mathew Thomas1, Amrendra Mandal2.   

Abstract

Merkel cell carcinoma (MCC) is a rare but highly aggressive skin cancer with neuroendocrine features. The important risk factors in the development of MCC include immunocompromised state, advanced age, and White skin complexion. The pathogenesis is associated with either the presence of Merkel cell polyomavirus or chronic exposure to ultraviolet radiation. MCC usually occurs in the sun-exposed areas of the skin and has the potential for regional and distant metastasis. Only 8% of the cases of MCC present with distant metastatic disease with liver, lungs, bone, and brain being commonly involved. Here, we report such an extremely rare case of a 78-year-old gentleman with a history of cutaneous T-cell lymphoma, who presented to the hospital with abnormally elevated liver enzymes, which on further evaluation was detected to have metastatic MCC of the liver.
Copyright © 2021, Thomas et al.

Entities:  

Keywords:  cutaneous t cell lymphoma; liver; merkel cell carcinoma; neuroendocrine; nivolumab

Year:  2021        PMID: 34956771      PMCID: PMC8675577          DOI: 10.7759/cureus.19659

Source DB:  PubMed          Journal:  Cureus        ISSN: 2168-8184


  18 in total

1.  Merkel cell carcinoma and multiple primary cancers.

Authors:  Regan A Howard; Graça M Dores; Rochelle E Curtis; William F Anderson; Lois B Travis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-08       Impact factor: 4.254

2.  UV-B-type mutations and chromosomal imbalances indicate common pathways for the development of Merkel and skin squamous cell carcinomas.

Authors:  Susanne Popp; Stefan Waltering; Christel Herbst; Ingrid Moll; Petra Boukamp
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

Review 3.  Merkel Cell Carcinoma: Updates on Staging and Management.

Authors:  Christine Cornejo; Christopher J Miller
Journal:  Dermatol Clin       Date:  2019-04-19       Impact factor: 3.478

4.  Somatostatin Receptors 2A and 5 Are Expressed in Merkel Cell Carcinoma with No Association with Disease Severity.

Authors:  Charlotte Gardair; Mahtab Samimi; Antoine Touzé; Pierre Coursaget; Gérard Lorette; Agnès Caille; Ewa Wierzbicka; Anne Croué; Martine Avenel-Audran; François Aubin; Rémy Kerdraon; Eric Estève; Nathalie Beneton; Serge Guyétant
Journal:  Neuroendocrinology       Date:  2015-02-26       Impact factor: 4.914

5.  PD-1 Blockade with Pembrolizumab in Advanced Merkel-Cell Carcinoma.

Authors:  Paul T Nghiem; Shailender Bhatia; Evan J Lipson; Ragini R Kudchadkar; Natalie J Miller; Lakshmanan Annamalai; Sneha Berry; Elliot K Chartash; Adil Daud; Steven P Fling; Philip A Friedlander; Harriet M Kluger; Holbrook E Kohrt; Lisa Lundgren; Kim Margolin; Alan Mitchell; Thomas Olencki; Drew M Pardoll; Sunil A Reddy; Erica M Shantha; William H Sharfman; Elad Sharon; Lynn R Shemanski; Michi M Shinohara; Joel C Sunshine; Janis M Taube; John A Thompson; Steven M Townson; Jennifer H Yearley; Suzanne L Topalian; Martin A Cheever
Journal:  N Engl J Med       Date:  2016-04-19       Impact factor: 91.245

Review 6.  Merkel cell carcinoma.

Authors:  Jürgen C Becker; Andreas Stang; James A DeCaprio; Lorenzo Cerroni; Celeste Lebbé; Michael Veness; Paul Nghiem
Journal:  Nat Rev Dis Primers       Date:  2017-10-26       Impact factor: 52.329

7.  Merkel cells and Merkel cell tumors. Ultrastructure, immunocytochemistry and review of the literature.

Authors:  T F Warner; H Uno; G R Hafez; J Burgess; C Bolles; R V Lloyd; M Oka
Journal:  Cancer       Date:  1983-07-15       Impact factor: 6.860

8.  Merkel cell carcinoma: Current US incidence and projected increases based on changing demographics.

Authors:  Kelly G Paulson; Song Youn Park; Natalie A Vandeven; Kristina Lachance; Hannah Thomas; Aude G Chapuis; Kelly L Harms; John A Thompson; Shailender Bhatia; Andreas Stang; Paul Nghiem
Journal:  J Am Acad Dermatol       Date:  2017-11-02       Impact factor: 11.527

9.  Early B-cell differentiation in Merkel cell carcinomas: clues to cellular ancestry.

Authors:  Axel Zur Hausen; Dorit Rennspiess; Veronique Winnepenninckx; Ernst-Jan Speel; Anna Kordelia Kurz
Journal:  Cancer Res       Date:  2013-04-10       Impact factor: 12.701

Review 10.  Systematic literature review of efficacy, safety and tolerability outcomes of chemotherapy regimens in patients with metastatic Merkel cell carcinoma.

Authors:  Paul Nghiem; Howard L Kaufman; Murtuza Bharmal; Lisa Mahnke; Hemant Phatak; Jürgen C Becker
Journal:  Future Oncol       Date:  2017-03-28       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.